摘要
尿酸是生理性的抗氧化剂,流行病学及临床资料显示低尿酸水平与帕金森病(PD)发病率增高密切相关,PD患者的血尿酸水平显著降低,高血尿酸水平能够降低PD的发病以及减慢PD的进展速度。尿酸转运体在尿酸分泌和重吸收过程中发挥关键作用,从而影响尿酸水平。本文将从尿酸转运体的角度介绍尿酸转运体与PD的研究进展。
Uric acid is a kind of physiological antioxidants. The epidemiology and clinical studies indicate that its lower level is closely related to the higher incidence of Parkinson's Disease(PD). The serum urate concentrations of PD patients are much lower. Lower incidence and better prognosis have been observed on PD patients with higher serum urate. Urate transporters affect urate secretion and reabsorption, which have a strong and apparent impact on urate concentrations. This review discusses current information on the characteristics of urate transporters, with specific focus on their association with PD.
引文
[1]Dorsey ER,Constantinescu R,Thompson JP,et al.Projected number of people with Parkinson disease in the most populous nations,2005 through 2030[J].Neurology,2007,68(5):384-386.
[2]Wright Willis A,Evanoff BA,Lian M,et al.Geographic and Ethnic Variation in Parkinson Disease:A Population-Based Study of US Medicare Beneficiaries[J].Neuroepidemiology,2010,34(3):143-151.
[3]Zimprieh A,Biskup S,Leitner P,et a1.Mutations in LRRK2 cause autosomal-dominant Parkinonism with pleomorphic pathology[J].Neuron,2004,44:601-607.
[4]Periquet M,Latouehe M,Lohmann E,et a1.Parkin mutations are frequent in patients with Isolated early-onset parkinsonism[J].Brain,2003,126(6):1271-1278.
[5]Valente EM,Abou-Sleiman PM,Caputo V,et al.Hereditary early—onset Parkinson’s disease caused by mutations in PINKI[J].Science,2004,304:1158-1160.
[6]Schwarzschild MA,Schwid SR,Marek K,et al.Serum urate as a predictor of clinical and radiographic progression in Parkinson disease[J].Arch Neurol,2008,65(6):716-723.
[7]王丽君,罗蔚锋,王恒会,等.尿酸对6-羟基多巴胺致大鼠黑质纹状体系毒性的影响[J].中华医学杂志,2010,90(19):1362-1365.
[8]朱红灿,蔡春生,耿利娇,等.尿酸对帕金森病模型大鼠多巴胺能神经元氧化应激的影响[J].中华老年医学杂志,2010,29(4):319-323.
[9]王晓君,罗蔚锋,王丽君,等.帕金森病患者认知功能与尿酸及相关因素分析[J].中华医学杂志,2009,89(23):156-158.
[10]朱红灿,耿利娇,蔡春生,等.尿酸对帕金森病大鼠学习记忆能力的影响及其机制[J].中华实验外科杂志,2010,27(2):227-229.
[11]Li S,Sanna S,Maschio A,et al.The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts[J].PLoS Genet,2007,3(11):2156-2162.
[12]Sica DA,Schoolwerth AC.Renal handling of organic anions and cations:excretion of uric acid.In:Brenner BM,editor.The Kidney[M].6th ed.Philadelphia:WB Saunders,2000:680-700.
[13]Dehghan A,Kottgen A,Yang Q,et al.Association of three genetic loci with uric acid concentration and risk of gout:a genome-wide association study[J].Lancet,2008,372:1953-1961.
[14]Caulfield MJ,Munroe PB,O’Neill D,et al.SLC2A9 is a high-capacity urate transporter in humans[J].PLoS Med,2008,5:197.
[15]Wallace C,Newhouse SJ,Braund P,et al.Genomewide association study identifies genes for biomarkers of cardiovascular disease:serum urate and dyslipidemia et al[J].Am J Hum Genet,2008,82:139-149.
[16]Stark K,Reinhard W,Neureuther K,et al.Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study[J].PLoS One,2008,3:1948.
[17]Vitart V,Rudan I,Hayward C,et al.SLC2A9 is a newly identified urate transporter influencing serum urate concentration,urate excretion and gout[J].Nat Genet,2008,40:437-442.
[18]Do ring A,Gieger C,Mehta D,et al.SLC2A9 influences uric acid concentrations with pro-nounced sex-specific effects[J].Nat Genet,2008,40:430-436.
[19]Brandstatter A,Kiechl S,Kollerits B,et al.Sex-specific association of the putative fructose trans-porter SLC2A9variants with uric acid levels is modified by BMI[J].Diabetes Care,2008,31:1662-1667.
[20]Kolz M,Johnson T,Sanna S,et al.Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations[J].Plos Genet,2009,5:1-10.
[21]Tu HP,Chen CJ,Tovosia S,et al.Associations of a nonsynonymous variant in SLC2A9 with gouty arthritis and uric acid levels in Han Chinese and Solomon Islanders[J].Ann Rheum Dis,2010,69:887-890.
[22]Hollis-Moffatt JE,Xu X,Dalbeth N,et al.Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori,Pacific Island,and Caucasian case-control sample sets[J].Arthritis Rheum,2009,60:3485-3492.
[23]Woodward OM,Kottgen A,Coresh J,et al.Identification of a urate transporter,ABCG2,with a common functional polymorphism causing gout[J].Proc Natl Acad Sci USA,2009,106:10338-10342.
[24]Kolz M,Johnson T,Sanna S,et al.Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations[J].Plos Genet,2009,5:1-10.
[25]Gene L.Bowman,Jackilen Shannon,Balz Frei,et al.Uric acid as a CNS antioxidant[J].J Alzheimers Dis,2010,19(4):1331-1336.
[26]Jedlitschky G,Grube M,Mosyagin I,et al.Targeting CNS transporters for treatment of neurodegenerative diseases[J].Curr Pharm Des,2013:19.[PubMed:23789959].
[27]Vitart V,Rudan I,Hayward C,et a1.SLC2A9 is a newly identifled urate transporter influencing serum urate concentration,urate excretion and gout[J].Nat Genet,2008,40:437-442.
[28]Anzai N,Jutabha P,Kimura T,et al.Urate transport:relationship with serum urate disorder[J].Curr Rheumatol Rev,2011,7:123-31.
[29]Maurizio F,Facheris·Andrew A.Variation in the Uric Acid Transporter Gene SLC2A9 and Its Association with AAO of Parkinson’s Disease[J].J Mol Neurosci,2011,43(3):246-250.
[30]Enomoto A,Kimura H,Chairoungdua A,et al.Molecular identification of a renal urate anion exchanger that regulates blood urate levels[J].Nature,2002,417:447-452.
[31]Ichida K,Hosoyamada M,Hisatome I,et al.Clinical and molecular analysis of patients with renal hypouricemia in Japan influence of URATl gene cnuirnary urate excretion[J].J Am Soc Nephrol,2004,15:164-173.
[32]Shima Y,Temya K,Ohta H.Association hetween intronic SNP in urate-anion exchanger gene,SLC22A12 and scram uric acid levels in Japanese[J].Life Sci,2006,79:2234-2237.
[33]Uchino H,Tamai I,Yamashita K,et al.P-aminohippuric acid transport at renal apical membrane mediated by human inorganic phosphate transporter NPTl[J].Bioehem Biophys Res Commun,2000,270:254-259.
[34]Burekhardt G,Burekhardt BC.In vitro and in viva evidence of the importance of organic anion transporters(OATs)in drug therapy[J].HandbExp Pharnmeol,2011,201:29-104.
[35]Hagos Y,Stein D,Ugele B,et al.Human renal organic anion transporter 4 operates as an asymmetric urate transporter[J].J Am Soc Nephrol,2007,18:430-439.
